Ayman Rezk

2.3k total citations
22 papers, 1.2k citations indexed

About

Ayman Rezk is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Ayman Rezk has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Ayman Rezk's work include Multiple Sclerosis Research Studies (10 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (6 papers). Ayman Rezk is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (6 papers). Ayman Rezk collaborates with scholars based in Canada, United States and Germany. Ayman Rezk's co-authors include Amit Bar‐Or, Rui Li, Jennifer L. Gommerman, Alexandre Prat, Craig S. Moore, Jack P. Antel, Yusei Miyazaki, Simon Fillatreau, Paul S. Giacomini and Frauke Zipp and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ayman Rezk

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayman Rezk Canada 16 670 527 241 208 174 22 1.2k
Alyssa Nylander United States 6 438 0.7× 380 0.7× 129 0.5× 173 0.8× 168 1.0× 12 866
Bieke Broux Belgium 20 605 0.9× 297 0.6× 230 1.0× 241 1.2× 178 1.0× 45 1.1k
Sterling Ortega United States 17 937 1.4× 402 0.8× 355 1.5× 142 0.7× 136 0.8× 33 1.4k
Jennifer L. Berard Canada 9 321 0.5× 220 0.4× 321 1.3× 238 1.1× 134 0.8× 9 929
Yusei Miyazaki Japan 18 840 1.3× 857 1.6× 156 0.6× 232 1.1× 157 0.9× 65 1.6k
Vanessa Beynon United States 16 393 0.6× 173 0.3× 113 0.5× 283 1.4× 105 0.6× 19 901
Takaaki Ishizu Japan 15 311 0.5× 733 1.4× 160 0.7× 277 1.3× 146 0.8× 22 1.2k
Rayomand Press Sweden 24 243 0.4× 210 0.4× 152 0.6× 207 1.0× 97 0.6× 65 1.5k
Undine Proschmann Germany 14 257 0.4× 486 0.9× 60 0.2× 211 1.0× 138 0.8× 29 778
Xiaonan Zhong China 20 266 0.4× 602 1.1× 105 0.4× 221 1.1× 88 0.5× 46 1.0k

Countries citing papers authored by Ayman Rezk

Since Specialization
Citations

This map shows the geographic impact of Ayman Rezk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Rezk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Rezk more than expected).

Fields of papers citing papers by Ayman Rezk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Rezk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Rezk. The network helps show where Ayman Rezk may publish in the future.

Co-authorship network of co-authors of Ayman Rezk

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Rezk. A scholar is included among the top collaborators of Ayman Rezk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Rezk. Ayman Rezk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bréville, Gautier, Mahdia Benkhoucha, Ayman Rezk, et al.. (2025). Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis. Annals of Neurology. 99(1). 261–273.
2.
Rezk, Ayman, et al.. (2024). Optical Properties of Spin‐Coated Solution Processed MoS2. SHILAP Revista de lepidopterología. 6(6).
3.
Rood, Julia E., Ayman Rezk, Jennifer Pogoriler, et al.. (2022). Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18. Journal of Clinical Immunology. 43(1). 101–108. 27 indexed citations
4.
Zuroff, Leah, Ayman Rezk, Koji Shinoda, et al.. (2022). Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age. EBioMedicine. 82. 104179–104179. 29 indexed citations
5.
Li, Rui, Thomas F. Tropea, Leah Zuroff, et al.. (2021). Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease. Neurology Neuroimmunology & Neuroinflammation. 9(2). 36 indexed citations
6.
Shinoda, Koji, Ayman Rezk, Rui Li, & Amit Bar‐Or. (2020). Early preferential repopulation of anti-inflammatory B cells following an initial treatment of ocrelizumab in patients with multiple sclerosis (4770). Neurology. 94(15_supplement). 1 indexed citations
7.
Rezk, Ayman, Rui Li, & Amit Bar‐Or. (2020). Multiplexed detection and isolation of viable low-frequency cytokine-secreting human B cells using cytokine secretion assay and flow cytometry (CSA-Flow). Scientific Reports. 10(1). 14823–14823. 4 indexed citations
8.
Ghadiri, Mahtab, Ayman Rezk, Rui Li, et al.. (2020). Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis. Scientific Reports. 10(1). 356–356. 23 indexed citations
9.
Ghadiri, Mahtab, Ayman Rezk, Rui Li, et al.. (2017). Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis. Neurology Neuroimmunology & Neuroinflammation. 4(3). e340–e340. 64 indexed citations
10.
Ghadiri, Mahtab, Ayman Rezk, Rui Li, et al.. (2017). Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod. Multiple Sclerosis Journal. 23(9). 1225–1232. 33 indexed citations
11.
Fleischer, Vinzenz, Ayman Rezk, Esther Witsch, et al.. (2017). Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS. Multiple Sclerosis Journal. 24(5). 632–641. 43 indexed citations
12.
Healy, Luke M., Gabrielle Perron, Mackenzie A. Michell‐Robinson, et al.. (2016). MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells. The Journal of Immunology. 196(8). 3375–3384. 121 indexed citations
13.
Li, Rui, Ayman Rezk, Luke M. Healy, et al.. (2016). Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis. Frontiers in Immunology. 6. 626–626. 79 indexed citations
14.
Fleischer, Vinzenz, Felix Luessi, Ayman Rezk, et al.. (2016). Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment. Multiple Sclerosis Journal. 23(4). 567–576. 15 indexed citations
15.
Li, Rui, Ayman Rezk, Felix Luessi, et al.. (2016). Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis. The Journal of Immunology. 198(2). 691–698. 99 indexed citations
16.
Rozenberg, Ayal, Ayman Rezk, Marie‐Noëlle Boivin, et al.. (2016). Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism. Stem Cells Translational Medicine. 5(11). 1506–1514. 76 indexed citations
17.
Li, Rui, Ayman Rezk, Yusei Miyazaki, et al.. (2015). Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy. Science Translational Medicine. 7(310). 310ra166–310ra166. 338 indexed citations
18.
Miyazaki, Yusei, Rui Li, Ayman Rezk, et al.. (2014). A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis. PLoS ONE. 9(8). e105421–e105421. 79 indexed citations
19.
Hossny, Elham, et al.. (2013). Fish sensitization in a group of allergic Egyptian children. 11(1). 1 indexed citations
20.
Hossny, Elham, et al.. (2010). Sea Food Allergy. 8(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alyssa Nylander Breakdown of academic impact, for papers by Bieke Broux Breakdown of academic impact, for papers by Sterling Ortega Breakdown of academic impact, for papers by Jennifer L. Berard Breakdown of academic impact, for papers by Yusei Miyazaki Breakdown of academic impact, for papers by Vanessa Beynon Breakdown of academic impact, for papers by Takaaki Ishizu Breakdown of academic impact, for papers by Rayomand Press Breakdown of academic impact, for papers by Undine Proschmann Breakdown of academic impact, for papers by Xiaonan Zhong
Rankless by CCL
2026